Skip to main content
XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.300
-0.090 (-3.77%)
At close: Apr 28, 2026, 4:00 PM EDT
2.350
+0.050 (2.17%)
After-hours: Apr 28, 2026, 4:10 PM EDT

XTL Biopharmaceuticals Revenue

XTL Biopharmaceuticals had revenue of $258.50K in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $968.00K. In the year 2024, XTL Biopharmaceuticals had annual revenue of $451.00K.

Revenue (ttm)
$968.00K
Revenue Growth
n/a
P/S Ratio
5.95
Revenue / Employee
$96,800
Employees
10
Market Cap
5.76M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024451.00K--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Jan 1, 2019 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Moolec Science 7.83M
CollPlant Biotechnologies 2.37M
Bio Green Med Solution 747.00K
PMGC Holdings 590.08K
BioRestorative Therapies 359.70K
Cardio Diagnostics Holdings 14.83K
Ernexa Therapeutics 1,000.00
Revenue Rankings

XTLB News

More News